TECH NEWS – During the interview, we learned that twelve of their patients have used the brain-computer interface (BCI) for nearly six years combined.

Neuralink is one of the few companies that implants tiny chips into the human brain, and its products are officially called BCIs. The company recently made headlines with its first patient, Noland Arbaugh, who was interviewed by Fortune magazine. Arbaugh revealed that, prior to receiving the Neuralink implant, he had spent eight years trying to make up for his lost mobility. He suffered an accident while swimming in 2016, which left him paralyzed from the waist down.

He received his Neuralink implant in 2024 and soon began playing video games and learning languages. He appears to be one of a dozen patients worldwide who have received Neuralink implants. Today, Neuralink announced on Twitter that 12 people worldwide are using its brain implants. The company added that these patients have used the devices for a total of 2,000 days and 15,335 hours. Neuralink recently performed its first surgery outside the United States. On August 27 and September 8, the company performed surgeries as part of a four-year clinical trial, as reported in a press release from the University Health Network (UHN) in Canada.

There are now 12 people around the world with Neuralink implants. Collectively, they’ve had their devices for 2,000 days and accumulated over 15,000 hours of use.

We look forward to continuing to explore the possibilities of neural interfaces with all of our participants! pic.twitter.com/OCuDN40abx

— Neuralink (@neuralink) September 9, 2025

This clinical trial will examine whether people with paralysis in all four limbs can use Neuralink implants to control devices with their thoughts. The Canadian trials are not the only ones being conducted by the company. In July, Neuralink announced that it had received approval from British regulators to launch the GB-Prime clinical trial. This trial will evaluate how paralyzed individuals can use devices and interact with the digital world through their thoughts.

As he has with all his other companies, Elon Musk has set ambitious goals for Neuralink. During a 2020 presentation, he revealed his ultimate goal of reducing the cost of the brain chip and related implant surgery to a few thousand dollars. Since then, Neuralink has come a long way, receiving FDA approval to begin human trials in 2023.

Source: WCCFTech